Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Current Leases (2018)

Charles River Laboratories International (CRL) posted quarterly Current Leases of $3.2 million for Q4 2018.

Charles River Laboratories International (CRL) Current Leases (2018) Analysis & Trends

Charles River Laboratories International's Current Leases history runs 1 years deep, the most recent figure standing at $3.2 million for Q4 2018.

  • In Q4 2018, Current Leases changed N/A year-over-year to $3.2 million; the TTM figure through Dec 2018 stood at $3.2 million (changed N/A YoY), while the FY2018 annual figure was $3.2 million, changed N/A from the prior year.
  • Current Leases for Q4 2018 stood at $3.2 million.
  • The five-year high for Current Leases was $3.2 million in Q4 2018, with the low at $3.2 million in Q4 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 180.30 Mn
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -

Historic Data

Download Data
DateValue
Dec 29, 2018 3.19 Mn